From Trial Design to CDISC Submission

2 Pages

Manage multiple, complex statistical analysis deliverables for a program of studies, CDISC compliant outputs, and data pooling for NDA submission to the FDA with minimal sponsor oversight.

Join for free to read

Case Study Demystifying CDISC standards

Case Study REIMAGINING CLINICAL TRIAL DESIGN

Case Study ERT TRIAL OVERSIGHT SOLUTION

Case Study Complying with GLP & CDISC SEND | Succeeding with Xybion ’ s…

More from StatXact

Case Study REIMAGINING CLINICAL TRIAL DESIGN

Case Study Adaptive Trial Accelerates FDA Approval

Case Study Enhanced Access to Innovative Bayesian Clinical Trial Designs

Case Study Use Of Real-World Evidence Expands To Transform Drug Development

Case Study

From Trial Design to CDISC Submission

From Trial Design to CDISC Submission

You Might Also Like

More from StatXact